In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β
© 2018 Elsevier Inc. Fibrosis is a pathophysiological state characterized by the excessive formation/deposition of fibrous extracellular matrix. Transforming growth factor-beta (TGF-β) is a central profibrotic mediator, and targeting TGF-β is a promising strategy in the development of drugs for the...
Saved in:
Main Authors: | Theerut Luangmonkong, Su Suriguga, Adhyatmika Adhyatmika, Amirah Adlia, Dorenda Oosterhuis, Chuthamanee Suthisisang, Koert P. de Jong, Henricus A.M. Mutsaers, Peter Olinga |
---|---|
Other Authors: | Aarhus Universitet |
Format: | Article |
Published: |
2019
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/47297 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Modified culture protocol for testing anti-fibrotic drugs using precision-cut liver slices
by: Theerut Luangmonkong, et al.
Published: (2020) -
A pathophysiological model of non-alcoholic fatty liver disease using precision-cut liver slices
by: Grietje H. Prins, et al.
Published: (2020) -
Distinct responses between healthy and cirrhotic human livers upon lipopolysaccharide challenge: possible implications for acute-on-chronic liver failure
by: Su Suriguga, et al.
Published: (2022) -
Host microbiota dictates the proinflammatory impact of LPS in the murine liver
by: Su Suriguga, et al.
Published: (2020) -
Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs
by: Raditya Iswandana, et al.
Published: (2020)